News

This week on Tuning Into The C-Suite, Managed Healthcare Executive Senior Editor Peter Wehrwein speaks with Assistant Professor of Public Health at New York Medical College, Adam Block. The two discuss Block's recent article published in MHE, "Profits of Publicly Traded Health Plans Surge Amid Requests for Higher Rates" and more.

Amid struggling providers, furloughs of essential workers, years of premium increases and record high earnings, for-profit health plans should consider options for directly helping their networks.

Research model shows that caps on out-of-pocket costs don't result in higher health plan spending.

In this part one of two series, Carolyn Langer, M.D., the chief medical officer, says the Massachusetts health plan mounted a big push on telehealth that includes in-person visit payment levels.

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.

It's early days yet because patent and other issues have kept FDA-approved biosimilars off the market, but Gary Lyman, M.D., M.P.H.. of the Fred Hutchinson Cancer Research Center says there's evidence of some effect on the price of cancer supportive drugs.

The chimeric antigen receptor (CAR) T cell therapy is the first of its kind for mantle cell lymphoma (MCL).

Many are anxious or down but finding silver linings amidst challenges; essential workers and boomers are faring better than most.

Esketamine (Spravato) can now be used to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.

Shielding means staying at home and limiting contact with members of the household. Research also calls into question on how effective it is in reducing the incidence of COVID-19.

Content of this article was sponsored by Arbor Pharmaceuticals, LLC. Copyright 2020. This Managed Healthcare Executive® publication provides key information regarding a review by Faraone, et al, which was originally published in the Journal of the American Academy of Child & Adolescent Psychiatry (doi: 10.1016/j.jaac.2019.06.012). The authors of the original review are Stephen V. Faraone, PhD; Anthony L. Rostain, MD; C. Brendan Montano, MD; Oren Mason, MD; Kevin M. Antshel, PhD; Jeffrey H. Newcorn, MD. Please consult the full published review for complete information.

Preliminary findings by Case Western researchers point to kallikrein-related peptidase 6 as possible culprit in the development of psoriatic arthritis.

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.

Artificial intelligence and machine learning can take on simple tasks in healthcare so people can focus on collaboration and work on a higher cognitive level.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.

Potential agents to battle inflammation and other processes move through development pipeline.

Now is the time to take serious action to reform wasteful hospital practices and strengthen the healthcare supply chain. The high cost of American healthcare has topped headlines for years.

Advocates say a number of regulatory changes could help bring more of these products on to the market.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.

Founder of the Camden Coalition and a SDOH pioneer is looking to establish a primary care clinic in southern New Jersey.

As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.

Briana Contreras speaks with Dan Knecht, Vice President of Clinical Product at CVS Health about telehealth, patient access, CVS minute clinics and Path to Better Health.

Underrepresentation of blacks in clinical trials is garnering special attention.

Managed Healthcare Executive® (MHE) interviewed Jeff Hawkins, president and CEO of Truvian Sciences, about how Truvian received an Emergency Use Authorization (EUA) from FDA for Easy Check COVID-19 IgM/IgG antibody test.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

Providers are under immense financial pressure because of COVID-19. More than ever, health systems, hospitals and physician practices are assuming the role of a bank, financing the cost of healthcare.